Clonazepam Recall 2025 Calendar. Fda Food Recall List 2025 Adel Miles (OTCQX: NDOI) ("Endo") announced today that one of its operating subsidiaries, Endo USA, Inc., is expanding its previously announced voluntary recall of Clonazepam Orally. • Clonazepam orally disintegrating tablets were distributed nationwide between January and October Q O Q S.
Clonazepam recall expanded due to misprinted packaging from www.10tv.com
(OTCQX: NDOI) ("Endo") announced today that one of its operating subsidiaries, Endo USA, Inc., is expanding its previously announced voluntary recall of Clonazepam Orally. would expand an existing recall of Clonazepam Orally Disintegrating Tablets, USP (C-IV) over concerns that the packaging had been mislabeled with the incorrect dosing.
Clonazepam recall expanded due to misprinted packaging
The drug clonazepam, used to treat anxiety, seizures and muscle spasms, is being recalled over a potentially fatal mislabeling mistake (OTCQX: NDOI) ("Endo") announced today that one of its operating subsidiaries, Endo USA, Inc., is expanding its previously announced voluntary recall of Clonazepam Orally. The Pennsylvania-based company Endo, Inc., issued a voluntary nationwide recall for Clonazepam Orally Disintegrating Tablets because "a limited number of cartons" were printed with the incorrect.
Product Recalls In 2025 By Fda List Sam Newman. announced that it was expanding its voluntary recall of clonazepam orally disintegrating tablets because a limited number of cartons may have been printed with the incorrect strength and National Drug Code by a third-party packager (FDA) recently announced that Endo USA, Inc., a Pennsylvania-based company, had recalled 113,331 packages of clonazepam medication
Clonazepam Recall Everything You Need to Know. According to the statement, certain product lots contained an incorrect National Drug Code (NDC) number and incorrect pill. Clonazepam oral tablet, Teva, 0.5 mg, bottle, 100 count, NDC 00093-0832-01; Reason for the Shortage